European Hand Sanitizer Market Expected to Reach $9.4 Billion by 2027.

Growing at a CAGR of 38.4% during 2019–2027. The European hand sanitizer market was valued at US$ 641.7 million in 2018 and is expected to...
Super Gonorrhea

Antibiotic-Resistant Super Gonorrhea (CDC).

"We are currently down to one last recommended and effective class of antibiotics, cephalosporins, to treat this common infection." "Gonorrhea is skilled at outsmarting the...

CDC’s Worst-Case Coronavirus Model: 214 Million Infected, 1.7 Million Dead (Intelligencer)

A recent CDC projection estimated that the U.S. coronavirus epidemic could infect between 160 million and 214 million people over a period of more...

‘Amazing potential.’ UM doctor to start stem cell trial for coronavirus patients (Miami Herald)

BY BEN CONARCK APRIL 16, 2020 A team of doctors at the University of Miami won emergency federal approval to use stem cell therapy on...
American BriVision

American BriVision (ABVC) Improves Working Capital and Reduce Debt.

American BriVision Announces Two Financial Transactions to Improve Working Capital and Reduce Debt FREMONT, CA, April 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – American...

FDA Authorizes Athersys (ATHX) to Initiate a Pivotal Clinical Trial!

FDA Authorizes Athersys to Initiate a Pivotal Clinical Trial Evaluating MultiStem® Cell Therapy in Patients With COVID-19 Induced Acute Respiratory Distress Syndrome. (Editors note: a...
Biotech Stock Review, Exsosomes

Exosomes, Extracellular Vesicles, and the CoronaVirus.

Uploading a Series of Articles on Extracellular Vesicles, Including Potential Effects on the CoronaVirus and ARDS. Article #1: the basics in non-scientific terms from Larry...
Corbus Pharma, Biotech Stock Review

Adding Corbis Pharma (CRBP) $5.55 to Watch List.

Running Clinical Trials Full Steam With $46 Million Banked in Late February. Not thinly, but lightly traded. Ready, locked and loaded. All of the common...
Athersys, Biotech Stock Review

Boo Ya. Brokerage Sets $12 Price Target for Athersys (ATHX) $2.96.

A major Wall Street firm that specializes in Bio and Medtech Companies has a $12 price target out on Athersys from one of its...
America BriVision, Biotech Stock Review

Adding American BriVision (ABVC) $2.00 to Watch List.

New client and an incubator, studying now. Thinly, thinly traded. We like what we've read so far about their vitreous substitute (eyeball fluid) called...

Latest article

GeoVax (GOVX) Conference Call and Transcript.

Excellent Presentation. You Can Listen for 40 Minutes, or Read it in About Ten, Halleluiah. Guess what we'll choose to do? For the life...

Sekur Private Data (SWISF) Awarded Distribution Agreement With Elyon International.

Top Ranked Defense, Government and Enterprise Contractor Trying to Break Over $0.06. We are still sitting on the edge of our seat waiting for contract news,...

Broker Dealer – AtlasClear (ATCH) Conference Call

"AtlasClear is being built as an integrated financial services platform that will bring capital markets origination, clearing, and banking together under a single architecture."...